At a glance
Cannabist is the retail identity created by Columbia Care in 2021 and later adopted as the name of its public parent company. Its dispensaries sell both third-party products and the operator’s own flower, pre-roll, vape, concentrate, edible and tablet lines. The profile now requires an important current qualifier: in March 2026, The Cannabist Company entered Canadian court-supervised restructuring while arranging asset sales and wind-downs.
From Columbia Care to Cannabist
Michael Abbott and Nicholas Vita co-founded Columbia Care in 2012. The business began in medical cannabis and grew into one of the early U.S. multistate operators, combining cultivation, manufacturing and dispensary licenses. In May 2021 it introduced Cannabist as a national retail concept intended to replace a patchwork of local store identities with one customer-facing system.
The parent company completed the name change from Columbia Care Inc. to The Cannabist Company Holdings Inc. in September 2023. That makes the terminology easy to confuse: “Cannabist” can mean an individual dispensary, the retail network, or—since the rebrand—the public company behind that network.
Founders and leadership
Abbott and Vita are the documented co-founders. Vita served as chief executive from the 2012 founding until January 2024, when David Hart became CEO and Jesse Channon became president. Leadership titles can change, so the company’s investor-relations leadership page is the proper source for any current executive check.
What the stores sell
Cannabist stores operate as licensed retailers, not as one uniform product label. Menus vary by state and may serve medical patients, adult-use customers, or both. Categories commonly include flower, pre-rolls, vaporizers, concentrates, edibles, oils and tablets. Availability, purchase rules and promotions are jurisdiction-specific; an item shown in one market should not be assumed to exist in another.
The company’s product portfolio
The operator has marketed several house brands. Seed & Strain spans flower, pre-rolls and vapes; Triple Seven is positioned around premium flower; Amber covers concentrates; Hedy focuses on edibles; Classix is a broader value-oriented line; PRESS has been used for tablets; gLeaf remains a regional product and retail identity; and dreamt has offered nighttime-positioned gummies and tinctures in select markets. These are brand architectures, not proof that every format is active in every state.
Footprint: use a dated snapshot
The store map has contracted through divestitures and operational changes. The company’s current investor overview describes licenses in ten U.S. jurisdictions and 58 facilities—43 dispensaries plus 15 cultivation or manufacturing sites—while expressly including locations subject to pending sale or wind-down. Older articles showing 90-plus dispensaries or a fixed seven-state Cannabist map are historical snapshots, not a reliable current store count.
For shopping, the live store locator is the better source. For corporate scale, the latest filing or restructuring notice controls. Those two sources answer different questions and should not be blended.
The 2026 restructuring
On March 24, 2026, the company and a Canadian affiliate began voluntary proceedings under Canada’s Companies’ Creditors Arrangement Act. It announced definitive agreements to sell its Ohio and Delaware operations, a non-binding memorandum for operations in six additional states, and an orderly wind-down for New York and Pennsylvania. Its Virginia sale had already closed in February 2026.
The company also sought Chapter 15 recognition in the United States. This is more precise than casually calling the entire company “bankrupt”: the CCAA is a Canadian restructuring process, while Chapter 15 concerns U.S. recognition of the foreign proceeding. Stores and menus may remain active during transactions, but ownership and branding can change.
Awards and claim limits
The company has described some product lines as award-winning, but no stable, itemized corporate award ledger was found in the sources used for this profile. Rather than turn marketing language into an unsupported trophy list, this page omits awards that cannot be tied to a named product, awarding body and year. Product effects and medical outcomes are likewise not presented as facts.
Research notes and sources
- The Cannabist Company investor overview and corporate site establish current structure, facilities and brand portfolio.
- The company’s May 2021 launch release documents the retail-brand debut; its September 2023 results document the parent-company rename.
- Company leadership releases and its 2022 annual report identify Michael Abbott and Nicholas Vita as co-founders.
- The March 24, 2026 restructuring release and court records govern current asset-sale and wind-down statements.
Because the restructuring is active, store ownership, markets and brand availability should be checked again before travel or purchase.